DWTX Stock Analysis: Buy, Sell, or Hold?
DWTX - Dogwood Therapeutics, Inc. Common Stock
$2.64
0.14 (5.82%)
▲
5d:
+27.91%
30d:
+75.67%
90d:
+47.21%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When DWTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: DWTX is 22.6% above its trading range ($2.15). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: DWTX is 22.6% above its trading range ($2.15). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: DWTX is currently trading at $2.63, which is considered extended relative to its 30-day fair value range of $1.46 to $2.15.
Technical Outlook: Technically, DWTX is showing sideways momentum. Immediate support is located at $1.75, while resistance sits at $2.77. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: DWTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+462.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DWTX is showing sideways momentum. Immediate support is located at $1.75, while resistance sits at $2.77. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: DWTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+462.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.46 -
$2.15
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+22.6% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 462.2% below Wall St target ($14.00)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.46 -
$2.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.75
Resistance Level
$2.77
Current Trend
Sideways
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.91
Wall Street Target
$14.00
(+462.2%)
Share & Embed Analysis
Last updated: August 24, 2026 2:09 PM ET
Data refreshes hourly during market hours. Next update: 3:09 PM
Data refreshes hourly during market hours. Next update: 3:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DWTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 62 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 37 SELL |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 47 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 43 HOLD |
